Cargando…
JYNNEOS vaccine safety monitoring in the Republic of Korea, 2022: a cross-sectional study
OBJECTIVES: With the recent global mpox outbreak, the JYNNEOS vaccine (Modified Vaccinia Ankara-Bavarian Nordic) was developed as a third-generation smallpox vaccine and initially favored for mpox immunization. Vaccine-associated side effects contribute to vaccine hesitancy. Consequently, tracking a...
Autores principales: | Lee, Jaeeun, Kwon, Seunghyun Lewis, Park, Jinhee, Bae, Hyuna, Lee, Hyerim, Kwon, Geun-Yong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korea Disease Control and Prevention Agency
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10626317/ https://www.ncbi.nlm.nih.gov/pubmed/37920899 http://dx.doi.org/10.24171/j.phrp.2023.0182 |
Ejemplares similares
-
Monkeypox Vaccination in the Republic of Korea: Identifying the High-Risk Target Group
por: Kwon, Seunghyun Lewis, et al.
Publicado: (2022) -
Safety Monitoring of JYNNEOS Vaccine During the 2022 Mpox Outbreak — United States, May 22–October 21, 2022
por: Duffy, Jonathan, et al.
Publicado: (2022) -
Safety monitoring of COVID-19 vaccination among adolescents aged 12 to 17 years old in the Republic of Korea
por: Kim, Seontae, et al.
Publicado: (2022) -
COVID-19 vaccine safety monitoring in Republic of Korea from February 26, 2021 to October 31, 2021
por: Hwang, Insob, et al.
Publicado: (2021) -
Safety monitoring of COVID-19 vaccines: February 26, 2021, To June 4, 2022, Republic of Korea
por: Lee, Yeon-Kyeng, et al.
Publicado: (2023)